VacZine Analytics  
MarketVIEW: Cocaine dependence vaccines

Published: July 2013

Cocaine is a highly addictive natural alkaloid where users experience a short-term feeling of energy and euphoria. The United Nations Office on Drugs and Crime (UNODC) estimates 0.3-0.5% of the world population aged 15-64 years used cocaine in 2009, corresponding to 14.3-20.5 million people. Potential adverse effects associated with cocaine use our cardiovascular disturbances, new logical effects, gastrointestinal complications and sudden death due to cardiac arrest/seizures. It is estimated that cocaine was involved in about 5100 deaths in the US in 2008.

There are currently no FDA-approved medications to treat cocaine addiction , although behavioural treatments have been proven to be effective in some cases. Some investigators are investigating a cocaine vaccine which would stimulate anti-cocaine antibody production, sequester the drug in the blood circulation and reduce the associated euphoric effects.

This MarketVIEW product is a comprehensive commercial opportunity assessment detailing the potential market for a cocaine dependence vaccine with a patient based value/volume forecast for the major seven markets to 2030. Two target product profiles (TPP) are forecasted with differing efficacy levels/administration profiles. The analysis also gives an up-to-date review of worldwide epidemiology/guidelines/classifications and an overview of current research and development in the field.

THIS PRODUCT IS COMPOSED OF SUMMARY PRESENTATION + 1 MODEL (optional)

To order please contact your region account manager, buy "on-line" or order direct at: orders@vaczine-analytics.com

CAT No: CONTENTS: PURCHASE:
VAMV048 Click here>>
Discounted option:

*Prices are quoted for either presentation or forecast model separately and are for 1 region license only. Regions are North America, or EU or ROW. For UK orders VAT will be added at 20%. Please review the TERMS and CONDITIONS of purchase.

Return to main list>> Questions about this report?






© 2013 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains